In yesterday’s Wall Street session, Science 37 Holdings Inc. (NASDAQ:SNCE) shares traded at $0.59, up 42.09% from the previous session.
5 analysts cover Science 37 Holdings Inc. (NASDAQ:SNCE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $2.50 and a low of $1.00, we find $2.00. Given the previous closing price of $0.41, this indicates a potential upside of 387.8 percent. SNCE stock price is now 129.24% away from the 50-day moving average and 32.20% away from the 200-day moving average. The market capitalization of the company currently stands at $65.13M.
The stock has received a hold rating from 1 analysts and a buy rating from 3. Brokers who have rated the stock have averaged $1.88 as their price target over the next twelve months.
In other news, Pellizzari Christine A, Chief Legal Officer bought 5,000 shares of the company’s stock on Nov 17. The stock was bought for $4,032 at an average price of $0.81. Upon completion of the transaction, the Chief Legal Officer now directly owns 5,000 shares in the company, valued at $2950.0. Insiders disposed of 5,614 shares of company stock worth roughly $3312.2599999999998 over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SNCE stock. A new stake in Science 37 Holdings Inc. shares was purchased by KINGSWOOD WEALTH ADVISORS, LLC during the first quarter worth $378,000. GSA CAPITAL PARTNERS LLP invested $103,000 in shares of SNCE during the first quarter. In the first quarter, OLD MISSION CAPITAL, LLC acquired a new stake in Science 37 Holdings Inc. valued at approximately $50,000. SUSQUEHANNA INTERNATIONAL GROUP, LLP acquired a new stake in SNCE for approximately $17,000. WELLS FARGO & COMPANY/MN purchased a new stake in SNCE valued at around $7,000 in the second quarter. In total, there are 82 active investors with 61.30% ownership of the company’s stock.
On Thursday morning Science 37 Holdings Inc. (NASDAQ: SNCE) stock kicked off with the opening price of $0.4480. During the past 12 months, Science 37 Holdings Inc. has had a low of $0.19 and a high of $2.53. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 5.90, and a quick ratio of 5.90. The fifty day moving average price for SNCE is $0.2640 and a two-hundred day moving average price translates $0.4411 for the stock.
The latest earnings results from Science 37 Holdings Inc. (NASDAQ: SNCE) was released for Mar, 2023. The company reported revenue of $15.35 million for the quarter, compared to $19.27 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -20.36 percent.
Science 37 Holdings Inc.(SNCE) Company Profile
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company’s platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
